These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 12678257)
1. Application of an in vitro endopeptidase assay for detection of residual toxin activity in tetanus toxoids. Leung T; Corran PH; Gee C; Ekong TA; Sesardic D Dev Biol (Basel); 2002; 111():327-32. PubMed ID: 12678257 [TBL] [Abstract][Full Text] [Related]
2. "BINACLE" assay for in vitro detection of active tetanus neurotoxin in toxoids. Behrensdorf-Nicol HA; Weisser K; Krämer B ALTEX; 2015; 32(2):137-42. PubMed ID: 25769344 [TBL] [Abstract][Full Text] [Related]
3. In vitro determination of tetanus toxicity by an endopeptidase assay linked to a ganglioside-binding step. Behrensdorf-Nicol HA; Bonifas U; Kegel B; Silberbach K; Krämer B; Weisser K Toxicol In Vitro; 2010 Apr; 24(3):988-94. PubMed ID: 20036726 [TBL] [Abstract][Full Text] [Related]
4. Residual enzymatic activity of the tetanus toxin light chain present in tetanus toxoid batches used for vaccine production. Behrensdorf-Nicol HA; Kegel B; Bonifas U; Silberbach K; Klimek J; Weiber K; Krämer B Vaccine; 2008 Jul; 26(31):3835-41. PubMed ID: 18554757 [TBL] [Abstract][Full Text] [Related]
5. In vitro determination of specific toxicity in tetanus vaccines. Kegel B; Bonifas U; Silberbach K; Krämer B; Weisser K Dev Biol (Basel); 2002; 111():27-33. PubMed ID: 12678222 [TBL] [Abstract][Full Text] [Related]
6. Binding and cleavage (BINACLE) assay for the functional in vitro detection of tetanus toxin: applicability as alternative method for the safety testing of tetanus toxoids during vaccine production. Behrensdorf-Nicol HA; Bonifas U; Hanschmann KM; Krämer B; Weißer K Vaccine; 2013 Dec; 31(52):6247-53. PubMed ID: 24156922 [TBL] [Abstract][Full Text] [Related]
7. An in vitro assay for detection of tetanus neurotoxin activity: using antibodies for recognizing the proteolytically generated cleavage product. Kegel B; Behrensdorf-Nicol HA; Bonifas U; Silberbach K; Klimek J; Krämer B; Weisser K Toxicol In Vitro; 2007 Dec; 21(8):1641-9. PubMed ID: 17826026 [TBL] [Abstract][Full Text] [Related]
8. Results of an international transferability study of the BINACLE (binding and cleavage) assay for in vitro detection of tetanus toxicity. Behrensdorf-Nicol HA; Bonifas U; Isbrucker R; Ottiger H; Tierney R; Hanschmann KM; Weisser K; Krämer B Biologicals; 2014 Jul; 42(4):199-204. PubMed ID: 24882365 [TBL] [Abstract][Full Text] [Related]
9. Cell biology. Progress by poisoning. Cutler D Nature; 1992 Oct; 359(6398):773. PubMed ID: 1436051 [No Abstract] [Full Text] [Related]
10. Physicochemical and immunochemical assays for monitoring consistent production of tetanus toxoid. Metz B; Tilstra W; van der Put R; Spruit N; van den Ijssel J; Robert J; Hendriksen C; Kersten G Biologicals; 2013 Jul; 41(4):231-7. PubMed ID: 23726755 [TBL] [Abstract][Full Text] [Related]
11. [Determination of tetanus toxin and toxoid by ELISA using monoclonal antibodies]. Burkin MA; Sviridov VV; Perelygina OV Prikl Biokhim Mikrobiol; 2004; 40(4):478-84. PubMed ID: 15455723 [TBL] [Abstract][Full Text] [Related]
12. Steps towards the development of a replacement in vitro test for quantification of antibodies to tetanus toxin during potency testing of vaccine. Southern J; Clements H; Spenceley L Dev Biol Stand; 1996; 86():343. PubMed ID: 8785983 [No Abstract] [Full Text] [Related]
13. Alternatives to the use of animals for bacterial toxins and antitoxins. Sesardic D Dev Biol Stand; 1999; 100():75-82. PubMed ID: 10616178 [TBL] [Abstract][Full Text] [Related]
14. An effective toxoid from tetanus toxin prepared by stepwise iodination of purified toxin. Soares HR; Nunes RL; Prado SM; Higashi HG; Heneine IF Biologicals; 1994 Mar; 22(1):29-33. PubMed ID: 8068311 [TBL] [Abstract][Full Text] [Related]
15. Interaction of solid-phase gangliosides with tetanus toxin and toxoid. Habermann E; Tayot JL Toxicon; 1985; 23(6):913-20. PubMed ID: 4095706 [TBL] [Abstract][Full Text] [Related]
16. In vitro biological activity and toxicity of tetanus and botulinum neurotoxins. Pellizzari R; Rossetto O; Washbourne P; Tonello F; Nicotera PL; Montecucco C Toxicol Lett; 1998 Dec; 102-103():191-7. PubMed ID: 10022253 [TBL] [Abstract][Full Text] [Related]
17. Transynaptic effects of tetanus neurotoxin in the oculomotor system. González-Forero D; Morcuende S; Alvarez FJ; de la Cruz RR; Pastor AM Brain; 2005 Sep; 128(Pt 9):2175-88. PubMed ID: 15987757 [TBL] [Abstract][Full Text] [Related]
18. A conformational change of C fragment of tetanus neurotoxin reduces its ganglioside-binding activity but does not destroy its immunogenicity. Yu R; Yi S; Yu C; Fang T; Liu S; Yu T; Song X; Fu L; Hou L; Chen W Clin Vaccine Immunol; 2011 Oct; 18(10):1668-72. PubMed ID: 21813664 [TBL] [Abstract][Full Text] [Related]
19. Is the test for irreversibility of tetanus toxoids still relevant? Behrensdorf-Nicol HA; Krämer B Vaccine; 2019 Mar; 37(13):1721-1724. PubMed ID: 30826145 [TBL] [Abstract][Full Text] [Related]
20. Human monoclonal ScFv that inhibits cellular entry and metalloprotease activity of tetanus neurotoxin. Indrawattana N; Sookrung N; Kulkeaw K; Seesuay W; Kongngoen T; Chongsa-nguan M; Tungtrongchitr A; Chaicumpa W Asian Pac J Allergy Immunol; 2010 Mar; 28(1):85-93. PubMed ID: 20527521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]